Literature DB >> 31915358

Clinicopathologic Features of Gastric and Gastrooesophageal Junction Adenocarcinoma.

F A Rima1, M Hussain, R K Dewan, M N Haque, T Sultana, F Chowdhury, M Aminullah, J N Ferdous.   

Abstract

Gastric cancer (GC) is one of the most common tumors and remains the second leading cause of cancer mortality in the world. The incidence of gastric carcinoma is declining in the last few years in some areas like USA, UK, Canada etc, because of reduction in chronic H. pylori infection, smoking, decrease use of smoked and salted food. The gastric carcinoma still remains a burden for Bangladesh as the prevalence of H. Pylori has not substantially decreases. Among the gastric carcinomas, adenocarcinomas are the most common type. So the study was performed to observe the location and histomorphologic pattern of Gastric and gastrooesophageal junction (GEJ) adenocarcinoma. This descriptive cross sectional study was carried out at the Department of Pathology, Dhaka Medical College, Dhaka, Bangladesh from January 2013 to December 2014. A total of 130 patients with primary gastric and GEJ adenocarcinomas were included in this study. All the cases were evaluated for routine histological examination. The age range of the patients was 17 to 80 years and male to female ratio was 2.25:1. Antrum is the most common (66.9%) site being affected, followed by GEJ (19.2%), body (13%) and fundus (0.76%). Tumors of the antrum and GEJ were found mostly in the late age. On macroscopic examination, the ulcerated tumor mass (69.2%) was most frequent then the others. Regarding histological examination, 84(64.6%) cases were intestinal type, 32(24.6%) diffuse and 14(10.8%) mixed type by Laurens classification. According to WHO classification, about half of the cases (49.2%) were tubular carcinoma and rest were others. Most of the intestinal type carcinoma (71.4%) was presented with moderately differentiated and 25.0% with well differentiated. Where as the diffuse type presented with poorly differentiated in 96.9% cases.

Entities:  

Year:  2020        PMID: 31915358

Source DB:  PubMed          Journal:  Mymensingh Med J        ISSN: 1022-4742


  5 in total

1.  An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas.

Authors:  Kangjie Zhou; Nan Hu; Yidong Hong; Xueyu Wu; Jingzhou Zhang; Huan Lai; Yang Zhang; Fenglei Wu
Journal:  Front Genet       Date:  2022-05-23       Impact factor: 4.772

2.  The Ferroptosis-Related Noncoding RNA Signature as a Novel Prognostic Biomarker in the Tumor Microenvironment, Immunotherapy, and Drug Screening of Gastric Adenocarcinoma.

Authors:  Xinming Chen; Zheng Zhu; Xiaoling Li; Xinyue Yao; Lianxiang Luo
Journal:  Front Oncol       Date:  2021-11-01       Impact factor: 6.244

3.  N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma.

Authors:  Yibin Zhao; Xiao Yan; Yu Wang; Juan Zhou; Yang Yu
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

4.  Diplopia as the First Sign of Gastric Carcinoma.

Authors:  Suzanna L Roohé; Ivan M Gan; Kim van der Weerd; Boaz Lopuhaä; Robert M Verdijk; Dion Paridaens
Journal:  Case Rep Ophthalmol       Date:  2021-10-26

5.  Risk Factors and Their Diagnostic Values for Ocular Metastases in Gastric Adenocarcinoma.

Authors:  Yue Chen; Yan-Chang Yang; Li-Ying Tang; Qian-Min Ge; Wen-Qing Shi; Ting Su; Hui-Ye Shu; Yi-Cong Pan; Rong-Bin Liang; Qiu-Yu Li; Yi Shao
Journal:  Cancer Manag Res       Date:  2021-07-23       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.